Clinical Trials Related to GlaxoSmithKline

Related studies linked through entity extraction aliases.

A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible

Status: RECRUITING
Phase: PHASE1/PHASE2

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy

Status: COMPLETED
Phase: PHASE2

Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps

Status: COMPLETED
Phase: PHASE3

A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female Participants

Status: COMPLETED
Phase: PHASE1

Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants

Status: COMPLETED
Phase: PHASE1

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults

Status: COMPLETED
Phase: PHASE1

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)

Status: COMPLETED
Phase: PHASE3

A Study of Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During Their Subsequent Uncomplicated Pregnancy

Status: WITHDRAWN
Phase: PHASE3

A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India

Status: COMPLETED
Phase: PHASE3

A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals

Status: COMPLETED
Phase: PHASE2

Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma

Status: RECRUITING
Phase: PHASE2

Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK3858279 in Healthy Caucasian, Chinese and Japanese Participants

Status: COMPLETED
Phase: PHASE1

A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age

Status: COMPLETED
Phase: PHASE3

Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy

Status: RECRUITING
Phase: PHASE2

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Status: TERMINATED
Phase: PHASE2

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

Status: RECRUITING
Phase: PHASE1/PHASE2

Study of GSK3511294 in Healthy Chinese Participants

Status: COMPLETED
Phase: PHASE1